Robert Pilz

Robert Pilz discloses dealings in NervGen Pharma Corp. to SEDI. In total, 7 filings cover trades dated from 19 February 2019 to 13 January 2020.

On the market, this insider has only sold: 6 sales, €107k in total. Since January 2020: no purchases and 2 sales on the market.

The newest entry dates from 17 January 2020: an open-market sale of €32k, in NervGen Pharma Corp. Filings reach the SEDI feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEDI. Past trades are no guide to future returns.